India, Bhutan review development cooperation, agree to implement new projects

The Indian government has committed Rs 4,500 crore for the implementation of development projects and Rs 400 crore for the transitional Trade Support Facility during Bhutan's 12th Five Year Plan (2018-2023).

PTI

June 28, 2021 / 11:05 PM IST

Bhutan | (Image: Reuters)

India and Bhutan reviewed the entire gamut of their development partnership on Monday with both sides agreeing to implement some new projects in the Himalayan nation across various sectors such as road infrastructure, water management and COVID-19 management.

The Third India-Bhutan Development Cooperation Talks were held virtually. While the Indian delegation was led by Rahul Chhabra, Secretary (Economic Relations), Ministry of External Affairs, the Bhutanese delegation was led by Kinga Singye, the Foreign Secretary, the Ministry of External Affairs said in a statement.

ALSO READ: Bhutan King Jigme Khesar Namgyel Wangchuck treks across mountains to hold down COVID-19 fatality count

The Indian government has committed Rs 4,500 crore for the implementation of development projects and Rs 400 crore for the transitional Trade Support Facility during Bhutan's 12th Five Year Plan (2018-2023), it said. As many as 77 large and intermediate projects and 524 Small Development Projects (SDPs)/High Impact Community Development Projects (HICDPs) are at various stages of implementation under the 12th Five Year Plan, the MEA said.

With Bhutan's 12th Five Year Plan (2018-2023) completing its third year, the two sides reviewed the overall progress of the ongoing Project Tied Assistance (PTA) projects, as well as the SDPs/HICDPs. Bhutan's Foreign Secretary commended India's role in the socio-economic transformation of the Himalayan nation and also highlighted the impact of HICDPs at the grassroots level, the MEA said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show